Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lengauer

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|June 9, 2007
Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomasRalf Ketter, Steffi Urbschat, Wolfram Henn, et al.
Bioinformatics (Oxford, England)|July 17, 2012
Paving the future: finding suitable ISMB venuesBurkhard Rost, Terry Gaasterland, Thomas Lengauer, et al.
Proteins|August 8, 2015
Large oligomeric complex structures can be computationally assembled by efficiently combining docked interfacesMatthias Dietzen, Olga V Kalinina, Katerina Taškova, et al.
Intervirology|January 31, 2012
Predicting response to antiretroviral treatment by machine learning: the EuResist projectMaurizio Zazzi, Francesca Incardona, Michal Rosen-Zvi, et al.
Nucleic Acids Research|December 1, 2006
Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repairGuido Plotz, Christoph Welsch, Luis Giron-Monzon, et al.
European Journal of Medical Research|November 23, 2013
Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohortMark Oette, Stefan Reuter, Rolf Kaiser, et al.
Plos One|February 9, 2010
Only slight impact of predicted replicative capacity for therapy response predictionHendrik Weisser, André Altmann, Saleta Sierra, et al.
Journal of Molecular Biology|May 4, 2019
Near-Neighbor Interactions in the NS3-4A Protease of HCV Impact Replicative Fitness of Drug-Resistant Viral VariantsNadezhda T Doncheva, Francisco S Domingues, David R McGivern, et al.
Journal of Hepatology|November 22, 2008
Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis CUlrike Mihm, Oliver Ackermann, Christoph Welsch, et al.
Antiviral Therapy|May 17, 2007
Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistanceAndre Altmann, Niko Beerenwinkel, Tobias Sing, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|June 9, 2007
Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomasRalf Ketter, Steffi Urbschat, Wolfram Henn, et al.
Bioinformatics (Oxford, England)|July 17, 2012
Paving the future: finding suitable ISMB venuesBurkhard Rost, Terry Gaasterland, Thomas Lengauer, et al.
Proteins|August 8, 2015
Large oligomeric complex structures can be computationally assembled by efficiently combining docked interfacesMatthias Dietzen, Olga V Kalinina, Katerina Taškova, et al.
Intervirology|January 31, 2012
Predicting response to antiretroviral treatment by machine learning: the EuResist projectMaurizio Zazzi, Francesca Incardona, Michal Rosen-Zvi, et al.
Nucleic Acids Research|December 1, 2006
Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repairGuido Plotz, Christoph Welsch, Luis Giron-Monzon, et al.
European Journal of Medical Research|November 23, 2013
Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohortMark Oette, Stefan Reuter, Rolf Kaiser, et al.
Plos One|February 9, 2010
Only slight impact of predicted replicative capacity for therapy response predictionHendrik Weisser, André Altmann, Saleta Sierra, et al.
Journal of Molecular Biology|May 4, 2019
Near-Neighbor Interactions in the NS3-4A Protease of HCV Impact Replicative Fitness of Drug-Resistant Viral VariantsNadezhda T Doncheva, Francisco S Domingues, David R McGivern, et al.
Journal of Hepatology|November 22, 2008
Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis CUlrike Mihm, Oliver Ackermann, Christoph Welsch, et al.
Antiviral Therapy|May 17, 2007
Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistanceAndre Altmann, Niko Beerenwinkel, Tobias Sing, et al.
Pageof 24